University of New Mexico life sciences spin-out Tyrosine Pharma announces name change to Zocere.
Tyrosine Pharma, a spin-out of the University of New Mexico focused on developing stroke therapies, has announced a name change.
Now known as Zocere, the Albuquerque-based firm said the name change better reflected its development of drugs to combat stroke and other neurological conditions.
Zocere raised $250,000 in seed backing last year from angel investment coalition New Mexico Angels.
Wayne Laslie, president and chief exectuive, said: “We all know someone who has been struck down by stroke and how frustrating…
